A Memorandum of Understanding has been entered into between Ceva Wildlife Research Fund, Ceva Animal Health and National Parks Board of Singapore and Mandai Wildlife Group.  It is intended to vaccinate endangered species against highly pathogenic avian influenza (HPAI) given the worldwide prevalence of avian influenza and the vulnerability of the Mandai sanctuary.  The pilot program will include immunization of the most vulnerable species including the white-backed vulture (Gyps africanus), the marbled teal (Marmaronetta angustirostris) and other raptors.  The pilot project will provide details on the immunologic response of recipient birds and will also assist duration of immunity.

The program essentially follows the emergency vaccination of the highly endangered California condor (Gymnogyps californianus) in 2023 preserving this species highly susceptible to avian influenza as a result of consuming carcasses of dead birds.

The Ceva Wildlife Research Fund will spearhead the practical aspects of the program using CEVA vaccines with the Mandai wildlife Group monitoring the health of birds.

Marc Prikazsky chairman and CEO of CEVA Animal Health and also president of CEVA Wildlife Research Fund stated, “This collaboration truly reflects the essence of the One Health approach – bringing together scientific innovation, veterinary knowledge and a commitment to wildlife conservation.

The joint scientific and monitoring committee with representatives of the participants will ensure release of information and publication of data that will benefit poultry health professionals.